fda warning letters compounded semaglutide october 2025 Drug compounders sue over declaration ending Wegovy shortage Lilly, Novo, Hims Get FDA

Adequate vitamin status matters for optimal health, though supplementation beyond sufficiency rarely produces additional benefits

The entire semaglutide dose escalation fits neatly within a single syringe

As Bellomo put it, The evidence is approaching the threshold where practical planning should begin in earnest, even as we await data on sustained real-world outcomes. GLP-1 medications may ultimately become an important driver of cardiometabolic health improvement, but translating clinical promise into measurable mortality experience will take years of real-world data

[PMC free article: PMC151031] [PubMed: 12093887] 139